4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer

Published:2020-11-23 Issue:3 Volume:39 Page:636-643
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Jacobson Blake A.,Ahmad Zeeshan,Chen Sierra,Waldusky Gabriella,Dillenburg Maxwell,Stoian Emilia,Cambron Daniel A.,Patel Anil J.,Patel Manish R.,Wagner Carston R.,Kratzke Robert A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-020-01036-8.pdf

Reference47 articles.

1. Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 136(4):731–745

2. Duncan R, Hershey JW (1983) Identification and quantitation of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis. J Biol Chem 258(11):7228–7235

3. Thumma SC, Kratzke RA (2007) Translational control: a target for cancer therapy. Cancer Lett 258(1):1–8

4. Silvera D, Formenti SC, Schneider RJ (2010) Translational control in cancer. Nat Rev Cancer 10(4):254–266

5. Hsieh AC, Ruggero D (2010) Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res 16(20):4914–4920

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications;Current Medicinal Chemistry;2023-04

2. Therapeutic targeting of eukaryotic initiation factor (eIF) 4E;Biochemical Society Transactions;2023-01-20

3. Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group;ChemMedChem;2023-01-19

4. (−)-Gossypol enhances the anticancer activity of epirubicin via downregulating survivin in hepatocellular carcinoma;Chemico-Biological Interactions;2022-09

5. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression;World Journal of Surgical Oncology;2022-03-03